Effectiveness and Safety of Different Rivaroxaban Dosage Regimens in Patients with Non-Valvular Atrial Fibrillation: A Nationwide, Population-Based Cohort Study
Abstract The objective of this study is to evaluate the effectiveness of different rivaroxaban dosage regimens in preventing ischemic stroke and systemic thromboembolism among Asians. A retrospective cohort study was conducted on data from nationwide insurance claims in Taiwan. Patients with non-val...
Guardado en:
Autores principales: | Hsin-Yi Huang, Shin-Yi Lin, Shou-Hsia Cheng, Chi-Chuan Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f39f53d69007441bb6454079715716c7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS.
por: Takanori Ikeda, et al.
Publicado: (2021) -
Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Bo Hu, et al.
Publicado: (2021) -
Rivaroxaban-Associated Bullous Pemphigoid in a Patient With Atrial Fibrillation
por: Jiaming (Calvin) Liang, MD, MSc, et al.
Publicado: (2021) -
Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
por: Liu Yaowu, et al.
Publicado: (2021) -
Economic evaluation of apixaban for the prevention of stroke in non-valvular atrial fibrillation in the Netherlands.
por: Jelena Stevanović, et al.
Publicado: (2014)